Stability Monitoring in Regulatory Post-Approval Changes
Available from Pharma SOP:
Click to read the full article.
Stability Testing Types
Stability Protocol Design for Biosimilar Comparability
Regulatory agencies such as the USFDA, EMA, and CDSCO require biosimilar manufacturers to demonstrate that their product remains stable and comparable to the reference product throughout its lifecycle. Stability studies support:
Click to read the full article.
Regulatory Feedback on Insufficient Thermal Cycle Testing
Available from Pharma SOP:
Click to read the full article.
Avoiding Study Bias in Long-Term and Intermediate Stability Data
Available from Pharma SOP:
Click to read the full article.
Freeze-Thaw Testing of Drug-Eluting Devices
Available from Pharma SOP:
Click to read the full article.
Stability Challenges in Biologic Combination Products
Combination products integrate a biologic drug with a device or delivery system. Common examples include:
Click to read the full article.
Regulatory Inspections Focused on Intermediate Stability Data
Available from Pharma SOP:
Click to read the full article.
Simulated Cold Chain Failures: Case Studies
Available from Pharma SOP:
Click to read the full article.
Long-Term vs Accelerated Stability Testing in Biopharmaceuticals
Biologic products are highly sensitive to environmental factors such as temperature, humidity, light, and mechanical stress. Instability can result in:
Click to read the full article.
Freeze-Thaw Testing During Formulation Development
Available from Pharma SOP:
Click to read the full article.